|
1
|
Clark IM, Swingler TE, Sampieri CL and
Edwards DR: The regulation of matrix metalloproteinases and their
inhibitors. Int J Biochem Cell Biol. 40:1362–1378. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bourboulia D and Stetler-Stevenson WG:
Matrix metalloproteinases (MMPs) and tissue inhibitors of
metalloproteinases (TIMPs): positive and negative regulators in
tumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lambert E, Dassé E, Haye B and Petitfrère
E: TIMPs as multifacial proteins. Crit Rev Oncol Hematol.
49:187–198. 2004. View Article : Google Scholar
|
|
4
|
Pilcher BK, Wang M, Qin XJ, Parks WC,
Senior RM and Welgus HG: Role of matrix metalloproteinases and
their inhibition in cutaneous wound healing and allergic contact
hypersensitivity. Ann NY Acad Sci. 878:12–24. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Candelario-Jalil E, Yang Y and Rosenberg
GA: Diverse roles of matrix metalloproteinases and tissue
inhibitors of metalloproteinases in neuroinflammation and cerebral
ischemia. Neuroscience. 158:983–994. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Crocker SJ, Pagenstecher A and Campbell
IL: The TIMPs tango with MMPs and more in the central nervous
system. J Neurosci Res. 75:1–11. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gomez DE, Alonso DF, Yoshiji H and
Thorgeirsson UP: Tissue inhibitors of metalloproteinases:
structure, regulation and biological functions. Eur J Cell Biol.
74:111–122. 1997.PubMed/NCBI
|
|
8
|
Swarnakar S, Paul S, Singh LP and Reiter
RJ: Matrix metalloproteinases in health and disease: regulation by
melatonin. J Pineal Res. 50:8–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leco KJ, Apte SS, Taniguchi GT, et al:
Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA
isolation and expression in adult mouse tissues. FEBS Lett.
401:213–217. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Melendez-Zajgla J, Del Pozo L, Ceballos G
and Maldonado V: Tissue inhibitor of metalloproteinases-4. The road
less traveled. Mol Cancer. 7:852008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cesca F, Baldelli P, Valtorta F and
Benfenati F: The synapsins: key actors of synapse function and
plasticity. Prog Neurobiol. 91:313–348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valtorta F, Pozzi D, Benfenati F and
Fornasiero EF: The synapsins: multitask modulators of neuronal
development. Semin Cell Dev Biol. 22:378–386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dyck BA, Beyaert MG, Ferro MA and Mishra
RK: Medial prefrontal cortical synapsin II knock-down induces
behavioral abnormalities in the rat: examining synapsin II in the
pathophysiology of schizophrenia. Schizophr Res. 130:250–259. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fassio A, Patry L, Congia S, et al: SYN1
loss-of-function mutations in autism and partial epilepsy cause
impaired synaptic function. Hum Mol Genet. 20:2297–2307. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brown AS: The environment and
susceptibility to schizophrenia. Prog Neurobiol. 93:23–58. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chang DM, Su WL and Chu SJ: The expression
and significance of intracellular T helper cytokines in systemic
lupus erythematosus. Immunol Invest. 31:1–12. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garay PA and McAllister AK: Novel roles
for immune molecules in neural development: implications for
neurodevelopmental disorders. Front Synaptic Neurosci. 2:1362010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lim NK, Villemagne VL, Soon CP, et al:
Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in
plasma reveals a decrease of MMP-2 in Alzheimer’s disease. J
Alzheimers Dis. 26:779–786. 2011.PubMed/NCBI
|
|
19
|
Lorenzl S, Albers DS, LeWitt PA, et al:
Tissue inhibitors of matrix metalloproteinases are elevated in
cerebrospinal fluid of neurodegenerative diseases. J Neurol Sci.
207:71–76. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Berretta S: Extracellular matrix
abnormalities in schizophrenia. Neuropharmacology. 62:1584–1597.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ban JY, Yoon KL, Kim SK, Kang S and Chung
JH: Promoter polymorphism (rs3755724, −55C/T) of tissue inhibitor
of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki
disease with coronary artery lesions in a Korean population.
Pediatr Cardiol. 30:331–335. 2009.
|
|
22
|
Nakanishi K, Sako M, Yata N, et al: A-20C
angiotensinogen gene polymorphism and proteinuria in childhood IgA
nephropathy. Pediatr Nephrol. 19:144–147. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gabriel SB, Schaffner SF, Nguyen H, et al:
The structure of haplotype blocks in the human genome. Science.
296:2225–2229. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim SK, Park HJ, Lee JS, et al:
Association of Niemann-pick disease, type C2 (NPC2) polymorphisms
with obesity in Korean population. Mol Cell Toxicol. 6:395–400.
2010.
|
|
25
|
Burkhardt J, Petit-Teixeira E, Teixeira
VH, et al: Association of the X-chromosomal genes TIMP1 and IL9R
with rheumatoid arthritis. J Rheumatol. 36:2149–2157. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Majsterek I, Markiewicz L, Przybylowska K,
et al: Association of MMP1-1607 1G/2G and TIMP1 372 T/C gene
polymorphisms with risk of primary open angle glaucoma in a Polish
population. Med Sci Monit. 17:417–421. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thompson AR, Drenos F, Hafez H and
Humphries SE: Candidate gene association studies in abdominal
aortic aneurysm disease: a review and meta-analysis. Eur J Vasc
Endovasc Surg. 35:19–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hegab AE, Sakamoto T, Uchida Y, et al:
Association analysis of tissue inhibitor of metalloproteinase2 gene
polymorphisms with COPD in Egyptians. Respir Med. 99:107–110. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Furuno K, Takada H, Yamamoto K, et al:
Tissue inhibitor of metalloproteinase 2 and coronary artery lesions
in Kawasaki disease. J Pediatr. 151:155–160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
O-Charoenrat P and Khantapura P: The role
of genetic polymorphisms in the promoters of the matrix
metalloproteinase-2 and tissue inhibitor of metalloproteinase-2
genes in head and neck cancer. Oral Oncol. 42:257–267. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen W, Stambolian D, Edwards AO, et al:
Genetic variants near TIMP3 and high-density lipoprotein-associated
loci influence susceptibility to age-related macular degeneration.
Proc Natl Acad Sci USA. 107:7401–7406. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ogata T, Shibamura H, Tromp G, et al:
Genetic analysis of polymorphisms in biologically relevant
candidate genes in patients with abdominal aortic aneurysms. J Vasc
Surg. 41:1036–1042. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peterson NB, Beeghly-Fadiel A, Gao YT, et
al: Polymorphisms in tissue inhibitors of metalloproteinases-2 and
-3 and breast cancer susceptibility and survival. Int J Cancer.
125:844–850. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee HJ, Song JY, Kim JW, et al:
Association study of polymorphisms in synaptic vesicle-associated
genes, SYN2 and CPLX2, with schizophrenia. Behav Brain Funct.
1:152005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Saviouk V, Moreau MP, Tereshchenko IV and
Brzustowicz LM: Association of synapsin 2 with schizophrenia in
families of Northern European ancestry. Schizophr Res. 96:100–111.
2007. View Article : Google Scholar : PubMed/NCBI
|
